Infection and antibiotics in the aetiology, prediction and prevention of preterm birth

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Infectious Diseases

Background:

• Spontaneous preterm labor is a complex syndrome with multiple causes, including infection.
• While infection's role is established, effective antibiotic interventions remain debated.
• Bacterial vaginosis is a recognized contributor to preterm birth.

Purpose of the Study:

• To evaluate the efficacy of antibiotic intervention for spontaneous preterm labor.
• To explore the role of the vaginal microbiome and maternal immune response in preterm birth.
• To identify optimal timing and patient selection for antibiotic therapy.

Main Methods:

• Systematic review of existing studies on antibiotic intervention for preterm birth.
• Analysis of studies focusing on antibiotics targeting bacterial vaginosis (e.g., clindamycin).
• Consideration of treatment timing (before 22 weeks gestation) and patient criteria (abnormal genital flora).

Main Results:

• Antibiotics active against bacterial vaginosis, when administered early (<22 weeks) to women with abnormal flora, may reduce preterm birth rates.
• Evidence suggests early intervention can prevent irreversible inflammatory damage.
• Current data highlights a need for more robust clinical trials.

Conclusions:

• Targeted antibiotic therapy for bacterial vaginosis shows promise in preventing preterm birth.
• Early intervention is crucial to mitigate inflammatory processes.
• Further research into the vaginal microbiome and maternal immune responses is essential for optimizing treatment strategies.